This topic contains a solution. Click here to go to the answer

Author Question: The Hawley-Smoot Tariff Act of 1930 a. lowered U.S. tariff rates to provide markets for European ... (Read 62 times)

abc

  • Hero Member
  • *****
  • Posts: 543
The Hawley-Smoot Tariff Act of 1930
 
  a. lowered U.S. tariff rates to provide markets for European goods.
  b. raised tariff rates and contributed positively to economic recovery worldwide.
  c. encouraged European nations to lower their tariff rates to enable U.S. companies to sell their goods abroad.
  d. did not pass.
  e. raised U.S. tariff rates, causing European nations to raise their rates and thus weaken international trade.

Question 2

By 1820, ___________________ _ percent of the nation's population were westerners.
 
  Fill in the blank(s) with correct word



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

katara

  • Sr. Member
  • ****
  • Posts: 305
Answer to Question 1

e

Answer to Question 2

twenty




abc

  • Member
  • Posts: 543
Reply 2 on: Aug 8, 2018
Thanks for the timely response, appreciate it


fatboyy09

  • Member
  • Posts: 358
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Liver spots have nothing whatsoever to do with the liver. They are a type of freckles commonly seen in older adults who have been out in the sun without sufficient sunscreen.

Did you know?

The immune system needs 9.5 hours of sleep in total darkness to recharge completely.

Did you know?

Eating carrots will improve your eyesight. Carrots are high in vitamin A (retinol), which is essential for good vision. It can also be found in milk, cheese, egg yolks, and liver.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library